Read the latest report on Movember's impact for men living with prostate cancer. 

This World Cancer Day, we’re proud to announce the release of our latest impact report describing the key projects accelerating prostate cancer research and outcomes for men living with the disease.

The Movember Foundation supports innovative global projects starting with early stage research into prostate cancer biology through to clinical trials. We hope to make a significant contribution to reducing prostate cancer mortality and improving the quality of life of men diagnosed and living with the disease, as well as for their partners, caregivers and families.

The case studies outlined in the report demonstrate that our investment strategy in the prostate cancer research field is having a positive impact and is progressing towards achieving our vision. Of the 22 projects showcased here, 10 are already showing significant progress towards translating innovative research ideas into potentially lifesaving treatments or programs that will help men.

Five of the projects illustrate treatment approaches being studied in men or are actually being evaluated in human clinical trials, with the potential to lead to significant new therapies. Another four project teams are preparing promising treatments for clinical trials in the next few years. 

Each year in the US, the Movember Foundation makes a significant investment in innovative research programs through our partners at the Prostate Cancer Foundation (PCF). To date, we have contributed approximately $39 million to PCF, funding 28 projects at prestigious institutions such as Memorial Sloan Kettering Cancer Center, Dana Farber Cancer Institute and Fred Hutchinson Cancer Research Center. The Movember Foundation-PCF Challenge Awards are multi-year team science projects that focus specifically on permanent solutions for lasting remissions in advanced prostate cancer patients. Our new Prostate Cancer Impact Report highlights the progress of many of these programs.

Although we have made significant strides forward, the investment into prostate cancer research must continue for us to reach our vision of fewer men dying from prostate cancer and an improved quality of life for those with the disease. With the help of our Mo Bros and Mo Sistas and the wider Movember Community, the Movember Foundation will continue to invest in our priority areas. We will also continue to invest in pushing the translation of research findings into clinical practice so that the men and families we serve get access to new treatments and services as quickly as possible.


Download the full Prostate Cancer Impact Report


Donate Now